NASDAQ: SERA - Sera Prognostics, Inc.

Yield per half year: +43.11%
Sector: Healthcare

Sera Prognostics, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.72 -100% -4.35 -100%
P/S 648.48 33.75 1821.33%
P/BV 2.83 4.82 -41.29%
P/FCF 0 61 -100%
Ev/Ebitda -5.09 -22.17 -77.06%
Ev/S 641.88 22.56 2745.39%
Ev/FCF -7.19 68.75 -110.46%
E/P 0 0.0178 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-12621.24 4.98 -253694.46% -35113.61 -64.06%
ROE -51.66 9.61 -637.45%
ROA -37.97 0.3443 -11130.4%
ROIC 0 7.63 -100%
ROS -11843.79 -25.17 46954.97%
ROCE -56.33 15.35 -466.97%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0481 -3.68 -98.69% -0.0413 +16.49%
Nеt Debt/Ebitda 0.0524 -3.44 -101.52%
Debt/Ratio 0.0195 0.1985 -90.19%
Debt/Equity 0 1.66 -100%
Debt/Net Income -0.0513 10.32 -100.5%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5473 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.498 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5473

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
750 -56.89 -1418.33%
Growth impulse Ebitda in 5 years 159.46 -54.68 -391.62%
Growth impulse Net Income in 5 years 77.66 -58.33 -233.14%
Growth impulse FCF in 5 years 40.8 -49.48 -182.46%
Growth impulse EPS in 5 years -2.39 -32.41 -92.63%
IP Score
4.01/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription